An Unusual Presentation of ANCA-Associated Glomerulonephritis, Graves Disease, and Multiple Autoimmune Syndrome in a Patient with Morphea (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0755; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Per KDIGO 2024 guidelines, first-line therapy for AAV is prednisone with either cyclophosphamide or rituximab. MPO-ANCA-positive crescentic glomerulonephritis has been reported in Graves' disease, highlighting the significance of screening for autoimmune thyroid disease in patients with AAV. This case emphasizes the need for AAV evaluation in patients with renal failure and other autoimmune conditions."
Clinical • ANCA Vasculitis • Endocrine Disorders • Fibrosis • Glomerulonephritis • Grave's Disease • Hematological Disorders • Immunology • Lupus Nephritis • Musculoskeletal Pain • Nephrology • Renal Disease • Scleroderma • Systemic Sclerosis • Vasculitis
|
|
Tanya Nazar; Mizba Basheer Patel; Edward Pierce
|